What is an Investigator Oversight Plan?
An Investigator Oversight Plan (also called a PI Supervisory Plan or Investigator Responsibilities Plan) is a formal document that outlines how a Principal Investigator (PI) will supervise and oversee all aspects of a clinical trial at their site. It ensures that the PI maintains adequate oversight of study staff, data collection, participant safety, and regulatory compliance throughout the trial. While FDA regulations hold the PI ultimately responsible for all trial activities, the oversight plan provides a written framework demonstrating how this responsibility is fulfilled — especially when trials involve sub-investigators, study coordinators, nurses, and other support staff.
No. The FDA does not provide a ready-made template for the Investigator Oversight Plan. Instead, the FDA issues guidance documents that describe the regulatory expectation for such a plan — leaving the format, structure, and content entirely to each site or institution to develop in a manner appropriate to their trial and context.
What the FDA Does Provide — Guidance Documents
The following two FDA guidance documents set out the expectations for investigator oversight without prescribing a specific template:
- Guidance for Industry: Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects
States that the investigator "should develop a plan for the supervision and oversight of the clinical trial at the site," covering supervision of all staff regardless of their qualifications, with ultimate responsibility residing with the PI. Provides the foundational content expectations for what an oversight plan must address. - Guidance for Industry: Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring
Assists sponsors and investigators in developing risk-based monitoring strategies and oversight plans, with the overarching goal of enhancing human subject protection and data quality by focusing oversight on the most important aspects of study conduct and reporting.
Institutional Templates — Where to Find Them
In the absence of an FDA template, several academic medical centers and research institutions have developed and publicly shared their own Investigator Oversight Plans or equivalent SOPs:
- Society for Clinical Research Sites (SCRS) — Principal Investigator Oversight Template (DOCX)
- University Hospital of Bristol and Weston (UHBW) — SOP 008 — Investigator Oversight of Research (PDF)
- LSU Health Sciences Center New Orleans — SOP 2.01(a) — Principal Investigator Oversight
- Infectious Disease Clinical Research Consortium (IDCRC) — MOP Section 14 — Study Oversight
- VCU Health — CR-AD-105 — Investigator Responsibilities
- University of Utah — UUSOP-04 — Investigator Responsibilities
- UF Health Cancer Center — PI Responsibilities and Oversight SOP
- UNC — Institute for Global Health & Infectious Diseases — SOP Library (PI Oversight Category)
- UNC Research — PI Supervisory Plan Template (DOCX)
Practical Guidance
When developing a site-specific Investigator Oversight Plan, use the FDA guidance documents above as the content framework (defining what the plan must address), and use the institutional SOPs above as structural models (defining how to organise and document it). The plan should be tailored to reflect your site's staffing, trial complexity, and therapeutic area.
